There is new hope for the prevention and treatment of metabolic diseases


Metabolic Solutions Development Company (MSDC) is a drug discovery and development company investigating new molecular targets and developing novel therapeutics to treat metabolic diseases associated with age-related mitochondrial dysfunction, especially insulin resistance and type 2 diabetes.

News to know

Cirius Therapeutics Completes $40 Million Series A Financing to Fund Phase 2b Study of MSDC-0602K in NASH, Adds to Executive Team (Frazier Healthcare Partners and Novo A/S lead new investment)